Literature DB >> 15846560

[S3-guideline conference "Colorectal Cancer" 2004].

W Schmiegel1, C Pox, G Adler, W Fleig, U R Fölsch, P Frühmorgen, U Graeven, W Hohenberger, A Holstege, T Kühlbacher, R Porschen, P Propping, J F Riemann, R Sauer, T Sauerbruch, H-J Schmoll, M Zeitz, H-K Selbmann.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15846560     DOI： 10.1055/s-2005-865098

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  7 in total

1.  Combined Chemotherapy with Mitomycin C, Folinic Acid, and 5-Fluorouracil (MiFoFU) as Salvage Treatment for Patients with Liver Metastases from Breast Cancer - a Retrospective Analysis.

Authors:  Michael H R Eichbaum; Anne-Sybil Gast; Thomas Bruckner; Andreas Schneeweiss; Christof Sohn
Journal:  Breast Care (Basel)       Date:  2008-08-11       Impact factor: 2.860

2.  Does a negative screening colonoscopy ever need to be repeated?

Authors:  H Brenner; J Chang-Claude; C M Seiler; T Stürmer; M Hoffmeister
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

Review 3.  [Neoadjuvant radiochemotherapy for rectal cancer].

Authors:  W Hohenberger; G Lahmer; R Fietkau; R S Croner; S Merkel; J Göhl; R Sauer
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

4.  Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.

Authors:  Romana Moench; Martin Gasser; Karol Nawalaniec; Tanja Grimmig; Amrendra K Ajay; Larissa Camila Ribeiro de Souza; Minghua Cao; Yueming Luo; Petra Hoegger; Carmen M Ribas; Jurandir M Ribas-Filho; Osvaldo Malafaia; Reinhard Lissner; Li-Li Hsiao; Ana Maria Waaga-Gasser
Journal:  Oncotarget       Date:  2022-10-19

Review 5.  [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].

Authors:  J C Becker; W Domschke; T Pohle
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

6.  [Individualization of guidelines. Approach for rectal cancer in UICC stages II and III].

Authors:  N Eismann; A Emmermann; C Zornig
Journal:  Chirurg       Date:  2014-02       Impact factor: 0.955

7.  Effect of total mesorectal excision on the outcome of rectal cancer after standardized postoperative radiochemotherapy: do randomized studies translate into clinical routine?

Authors:  Ludwig Keilholz; Mesud Mese; Klaus Henneking; Jochen Willner
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.